$ARTH News Article - Arch Therapeutics Announces AC5 Self-Assembling Peptide Technology Platform Demonstrates Antimicrobial Activity in Two Studies and Provides CE Marking Status Update for AC5(TM) Topical Hemostat
https://marketwirenews.com/news-releases/arch...90864.html